CA3221371A1 - Novel particle composition comprising sialic acid binding ligand - Google Patents

Novel particle composition comprising sialic acid binding ligand Download PDF

Info

Publication number
CA3221371A1
CA3221371A1 CA3221371A CA3221371A CA3221371A1 CA 3221371 A1 CA3221371 A1 CA 3221371A1 CA 3221371 A CA3221371 A CA 3221371A CA 3221371 A CA3221371 A CA 3221371A CA 3221371 A1 CA3221371 A1 CA 3221371A1
Authority
CA
Canada
Prior art keywords
solvent
particles
composition
acid
sialic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3221371A
Other languages
English (en)
French (fr)
Inventor
Bin Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytodigm Inc
Original Assignee
Cytodigm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytodigm Inc filed Critical Cytodigm Inc
Publication of CA3221371A1 publication Critical patent/CA3221371A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
CA3221371A 2021-06-08 2022-06-08 Novel particle composition comprising sialic acid binding ligand Pending CA3221371A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163208150P 2021-06-08 2021-06-08
US63/208,150 2021-06-08
PCT/US2022/032674 WO2022261207A1 (en) 2021-06-08 2022-06-08 Novel particle composition comprising sialic acid binding ligand

Publications (1)

Publication Number Publication Date
CA3221371A1 true CA3221371A1 (en) 2022-12-15

Family

ID=84426331

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3221371A Pending CA3221371A1 (en) 2021-06-08 2022-06-08 Novel particle composition comprising sialic acid binding ligand

Country Status (7)

Country Link
US (1) US20240358653A1 (https=)
EP (1) EP4351520A4 (https=)
JP (1) JP2024522163A (https=)
CN (1) CN117750946A (https=)
AU (1) AU2022289003A1 (https=)
CA (1) CA3221371A1 (https=)
WO (1) WO2022261207A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118178673B (zh) * 2024-04-07 2024-11-05 铭畅生物医药南通有限公司 一种唾液酸酯环糊精包合物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009539793A (ja) * 2006-06-08 2009-11-19 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 診断及び治療用途のための官能化された固体ポリマーナノ粒子
WO2008039920A2 (en) * 2006-09-27 2008-04-03 Board Of Regents, The University Of Texas System Temperature-sensitive nanoparticles for controlled drug delivery
US20100009007A1 (en) * 2008-07-10 2010-01-14 Baxter International Inc. Non-covalent modification of microparticles and process of preparing same
US20110256059A1 (en) * 2008-10-28 2011-10-20 Universidade De Santiago De Compostela Nanoparticulate systems prepared from anionic polymers
GB0922066D0 (en) * 2009-12-17 2010-02-03 Univ Belfast Modulator
US9241913B2 (en) * 2011-05-19 2016-01-26 Syracuse University Polysialic acid-based N-trimethyl chitosan gel nanoparticles for systemic drug delivery
ES2711669A1 (es) * 2017-11-02 2019-05-06 Univ Santiago Compostela Sistemas de liberacion de farmacos de acido polisialico y metodos
CN114072130A (zh) * 2019-05-28 2022-02-18 法斯瑞斯公司 表面有硫酸根基团的微粒和纳米粒子

Also Published As

Publication number Publication date
AU2022289003A1 (en) 2023-12-21
US20240358653A1 (en) 2024-10-31
WO2022261207A1 (en) 2022-12-15
EP4351520A4 (en) 2025-04-02
EP4351520A1 (en) 2024-04-17
CN117750946A (zh) 2024-03-22
JP2024522163A (ja) 2024-06-11

Similar Documents

Publication Publication Date Title
US12070508B2 (en) Microparticles and nanoparticles having sulfate groups on the surface
US20210169819A1 (en) Microparticles and nanoparticles having negative surface charges
US12582612B2 (en) Pharmaceutical composition of Siglec-binding agents
JP2024038199A (ja) 細菌由来ミニ細胞を含む組成物およびそれを使用する方法
TWI895708B (zh) 用於治療ｔｒｏｐ－２表現性癌症之組合療法
JP7061134B2 (ja) 薬剤負荷ナノ粒子が表面に結合したｃａｒ ｔ細胞の養子移入およびその使用
US20220175689A1 (en) Novel drug delivery composition and process for blood-brain barrier crossing
TW202345901A (zh) 用於治療結腸直腸癌之組合療法
EP3936121A1 (en) Self assembling molecules for targeted drug delivery
US20240358653A1 (en) Novel particle composition comprising sialic acid binding ligand
WO2025250539A9 (en) Pharmaceutical composition comprising sialic acid for treating diseases related to the lung
US20240197642A1 (en) Novel drug delivery composition and process for blood-brain barrier crossing
US20240091351A1 (en) FOCAL IONIZING RADIATION AND CD47/SIRPa DISRUPTION ANTICANCER COMBINATION THERAPY
HK40065002A (en) Self assembling molecules for targeted drug delivery
HK40045237A (en) Compositions comprising bacterially derived minicells and methods of using the same

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250606

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250606